Arunjyothi Bio Ventures Limited (BOM:530881)
7.01
+0.12 (1.74%)
At close: Jan 22, 2026
Arunjyothi Bio Ventures Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Operating Revenue | 254.84 | 278.84 | 204.32 | 17.35 | 29.71 | 55.13 | Upgrade |
| 254.84 | 278.84 | 204.32 | 17.35 | 29.71 | 55.13 | Upgrade | |
Revenue Growth (YoY) | -17.64% | 36.48% | 1077.40% | -41.59% | -46.11% | -24.57% | Upgrade |
Cost of Revenue | 84.31 | 120.1 | 118.61 | 14.96 | 28.75 | 46.67 | Upgrade |
Gross Profit | 170.53 | 158.74 | 85.71 | 2.4 | 0.96 | 8.46 | Upgrade |
Selling, General & Admin | 104.44 | 91.84 | 46.64 | 0.08 | 0.66 | 2.41 | Upgrade |
Other Operating Expenses | 20.65 | 16.76 | 11.23 | 0.66 | -0.47 | 5.08 | Upgrade |
Operating Expenses | 157.47 | 139.06 | 78.01 | 0.74 | 0.19 | 7.49 | Upgrade |
Operating Income | 13.06 | 19.68 | 7.7 | 1.65 | 0.77 | 0.97 | Upgrade |
Interest Expense | -23.65 | -25.74 | -21.05 | -0.02 | -0 | -0.04 | Upgrade |
Interest & Investment Income | 2.81 | 2.81 | 0.37 | - | - | - | Upgrade |
Currency Exchange Gain (Loss) | - | - | - | - | - | 0.02 | Upgrade |
Other Non Operating Income (Expenses) | -2.03 | -0.16 | -0 | -0.05 | -0.01 | -0.02 | Upgrade |
Pretax Income | -9.81 | -3.41 | -12.99 | 1.58 | 0.76 | 0.92 | Upgrade |
Income Tax Expense | 16.59 | 14.81 | -9.5 | 0.41 | 0.2 | 0.24 | Upgrade |
Net Income | -26.4 | -18.22 | -3.49 | 1.17 | 0.56 | 0.68 | Upgrade |
Net Income to Common | -26.4 | -18.22 | -3.49 | 1.17 | 0.56 | 0.68 | Upgrade |
Net Income Growth | - | - | - | 107.62% | -17.59% | -35.43% | Upgrade |
Shares Outstanding (Basic) | 198 | 186 | 21 | 21 | 21 | 21 | Upgrade |
Shares Outstanding (Diluted) | 198 | 186 | 21 | 21 | 21 | 21 | Upgrade |
Shares Change (YoY) | 91.84% | 800.00% | -0.01% | 0.01% | - | - | Upgrade |
EPS (Basic) | -0.13 | -0.10 | -0.17 | 0.06 | 0.03 | 0.03 | Upgrade |
EPS (Diluted) | -0.14 | -0.10 | -0.17 | 0.06 | 0.03 | 0.03 | Upgrade |
EPS Growth | - | - | - | 107.41% | -18.09% | -35.37% | Upgrade |
Free Cash Flow | 52.31 | -44.22 | -163.08 | -322.54 | -7.82 | -3.12 | Upgrade |
Free Cash Flow Per Share | 0.27 | -0.24 | -7.88 | -15.57 | -0.38 | -0.15 | Upgrade |
Gross Margin | 66.92% | 56.93% | 41.95% | 13.80% | 3.24% | 15.34% | Upgrade |
Operating Margin | 5.12% | 7.06% | 3.77% | 9.53% | 2.60% | 1.75% | Upgrade |
Profit Margin | -10.36% | -6.53% | -1.71% | 6.73% | 1.89% | 1.24% | Upgrade |
Free Cash Flow Margin | 20.52% | -15.86% | -79.81% | -1858.69% | -26.31% | -5.65% | Upgrade |
EBITDA | 44.59 | 49.3 | 27.83 | - | - | - | Upgrade |
EBITDA Margin | 17.50% | 17.68% | 13.62% | - | - | - | Upgrade |
D&A For EBITDA | 31.54 | 29.62 | 20.13 | - | - | - | Upgrade |
EBIT | 13.06 | 19.68 | 7.7 | 1.65 | 0.77 | 0.97 | Upgrade |
EBIT Margin | 5.12% | 7.06% | 3.77% | 9.53% | 2.60% | 1.75% | Upgrade |
Effective Tax Rate | - | - | - | 25.98% | 26.00% | 26.00% | Upgrade |
Revenue as Reported | 255.78 | 281.65 | 204.68 | 17.35 | 32.51 | 55.15 | Upgrade |
Advertising Expenses | - | 0.06 | 0.14 | - | 0.02 | 0.03 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.